Robert L. Ferris
Robert L. Ferris
Verified email at
Cited by
Cited by
Nivolumab for recurrent squamous-cell carcinoma of the head and neck
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
N Engl J Med 375, 1856-1867, 2016
Head and neck cancer
A Argiris, MV Karamouzis, D Raben, RL Ferris
The Lancet 371 (9625), 1695-1709, 2008
Integrated genomic characterization of papillary thyroid carcinoma
N Agrawal, R Akbani, B ŠArman Aksoy, A Ally, H Arachchi, SL Asa, ...
Cell 159 (3), 676-690, 2014
Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples
YE Nikiforov, NP Ohori, SP Hodak, SE Carty, SO LeBeau, RL Ferris, L Yip, ...
The Journal of Clinical Endocrinology & Metabolism 96 (11), 3390-3397, 2011
The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction
NE Scharping, AV Menk, RS Moreci, RD Whetstone, RE Dadey, ...
Immunity 45 (2), 374-388, 2016
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive BiomarkersMutation of PI3K Pathway in Head and Neck Cancer
VWY Lui, ML Hedberg, H Li, BS Vangara, K Pendleton, Y Zeng, Y Lu, ...
Cancer discovery 3 (7), 761-769, 2013
Immunology and immunotherapy of head and neck cancer
RL Ferris
Journal of clinical oncology 33 (29), 3293-3304, 2015
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by†…
RL Ferris, G Blumenschein Jr, J Fayette, J Guigay, AD Colevas, L Licitra, ...
Oral oncology 81, 45-51, 2018
Lipid accumulation and dendritic cell dysfunction in cancer
DL Herber, W Cao, Y Nefedova, SV Novitskiy, S Nagaraj, VA Tyurin, ...
Nature medicine 16 (8), 880-886, 2010
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay
YE Nikiforov, SE Carty, SI Chiosea, C Coyne, U Duvvuri, RL Ferris, ...
Cancer 120 (23), 3627-3634, 2014
Interferon-γ drives Treg fragility to promote anti-tumor immunity
AE Overacre-Delgoffe, M Chikina, RE Dadey, H Yano, EA Brunazzi, ...
Cell 169 (6), 1130-1141. e11, 2017
The mutational landscape of adenoid cystic carcinoma
AS Ho, K Kannan, DM Roy, LGT Morris, I Ganly, N Katabi, D Ramaswami, ...
Nature genetics 45 (7), 791-798, 2013
E1308: phase II trial of induction chemotherapy followed by reduced-dose radiation and weekly cetuximab in patients with HPV-associated resectable squamous cell carcinoma of†…
S Marur, S Li, AJ Cmelak, ML Gillison, WJ Zhao, RL Ferris, WH Westra, ...
Journal of Clinical Oncology 35 (5), 490-497, 2017
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
EEW Cohen, RB Bell, CB Bifulco, B Burtness, ML Gillison, KJ Harrington, ...
Journal for immunotherapy of cancer 7 (1), 1-31, 2019
The changing therapeutic landscape of head and neck cancer
JD Cramer, B Burtness, QT Le, RL Ferris
Nature reviews Clinical oncology 16 (11), 669-683, 2019
Tumor antigen–targeted, monoclonal antibody–based immunotherapy: clinical response, cellular immunity, and immunoescape
RL Ferris, EM Jaffee, S Ferrone
Journal of Clinical Oncology 28 (28), 4390-4399, 2010
Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial
FJ Civantos, RP Zitsch, DE Schuller, A Agrawal, RB Smith, R Nason, ...
Journal of clinical oncology 28 (8), 1395, 2010
Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck
I Kuss, B Hathaway, RL Ferris, W Gooding, TL Whiteside
Clinical cancer research 10 (11), 3755-3762, 2004
Impact of the multi-gene ThyroSeq next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance/follicular lesion of†…
YE Nikiforov, SE Carty, SI Chiosea, C Coyne, U Duvvuri, RL Ferris, ...
Thyroid 25 (11), 1217-1223, 2015
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related†…
KJ Harrington, RL Ferris, G Blumenschein, AD Colevas, J Fayette, ...
The Lancet Oncology 18 (8), 1104-1115, 2017
The system can't perform the operation now. Try again later.
Articles 1–20